Shares of ProMetic Life Sciences Inc. (TSE:PLI – Get Free Report) rose 0.2% during mid-day trading on Monday . The company traded as high as C$13.72 and last traded at C$13.60. Approximately 921 shares changed hands during trading, a decline of 88% from the average daily volume of 8,002 shares. The stock had previously closed at C$13.57.
ProMetic Life Sciences Trading Up 0.2 %
The business has a 50-day moving average of C$13.60. The company has a market cap of C$317.06 million and a price-to-earnings ratio of -0.22. The company has a debt-to-equity ratio of 37.47, a current ratio of 4.06 and a quick ratio of 3.66.
About ProMetic Life Sciences
Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.
Featured Articles
- Five stocks we like better than ProMetic Life Sciences
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- How Much Can You Make in Stocks in One Month?
- How to Calculate Stock Profit
- This Is the Top Large-Cap Stock Insiders Are Buying
- How Can Investors Benefit From After-Hours Trading
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
